´╗┐Final intra-assay CV was 0

´╗┐Final intra-assay CV was 0.0% to 9.4% and inter-assay CV was 1.3% to 8.8%. 10?4) or controls (4.5% of 156, OR = 7.1, 95% CI = 3.1 – KC01 16.2, P = 9.3 10?6). Anti-TRIB2 positivity in controls was not associated with narcolepsy-cataplexy cases, the presence of anti-TRIB2 was associated with short disease duration (2.3 […]